ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,479.21
0.93%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) Noticias

CYTK Cytokinetics Inc

65.27
0.93 (1.45%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cytokinetics Inc CYTK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.93 1.45% 65.27 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
66.08 65.00 66.605 65.27 64.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/4/202415:00GLOBECytokinetics to Host Investor Event and Conference Call to..
24/4/202415:00GLOBECytokinetics to Announce First Quarter Results on May 8,..
10/4/202406:30GLOBECytokinetics Announces Three Late Breaking Clinical Trial..
05/4/202406:30GLOBECytokinetics Presents Additional 48-Week Data From..
02/4/202415:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
01/4/202415:00GLOBECytokinetics to Participate in the 23rd Annual Needham..
25/3/202407:15GLOBECytokinetics Announces Four Upcoming Presentations at the..
07/3/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:21EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:00GLOBECytokinetics to Participate in March Investor Conferences
01/3/202417:47PRNUSSuper Micro Computer and Deckers Outdoor Set to Join S&P..
01/3/202415:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/2/202406:30GLOBECytokinetics Joins Global Initiative to Recognize..
28/2/202406:30GLOBECytokinetics, The Mended Hearts, Inc. and WomenHeart..
27/2/202415:05EDGAR2Form 8-K - Current report
27/2/202415:00GLOBECytokinetics Reports Fourth Quarter 2023 Financial Results
14/2/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:03EDGAR2Form 144 - Report of proposed sale of securities
13/2/202415:11EDGAR2Form 144 - Report of proposed sale of securities
13/2/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:00GLOBECytokinetics to Announce Fourth Quarter Results on February..
06/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:10EDGAR2Form 144 - Report of proposed sale of securities
06/2/202415:00GLOBECytokinetics to Participate in the Oppenheimer 34th Annual..
02/2/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:38EDGAR2Form 8-K - Current report
31/1/202415:02EDGAR2Form 144 - Report of proposed sale of securities
29/1/202406:30GLOBECytokinetics Announces Recipients of Its Sixth Annual..
25/1/202406:30GLOBECytokinetics Presents New Data at CMR 2024 From FOREST-HCM, ..
22/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:49EDGAR2Form 144 - Report of proposed sale of securities
18/1/202412:00GLOBECytokinetics Announces New Data From FOREST-HCM to be..
12/1/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:09EDGAR2Form 144 - Report of proposed sale of securities
12/1/202405:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11/1/202412:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
08/1/202412:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
04/1/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:02EDGAR2Form 144 - Report of proposed sale of securities
03/1/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
CYTK
Cytokinetics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados